FoxP3+ T-regs were also expanded compared to controls, in the blood of LCH patients with active disease, among whom seven out of seven tested exhibited an impaired skin delayed-type hypersensitivity response. This evidence concerns the gene FOXP3 and Langerhans cell histiocytosis.